ClinicalTrials.Veeva

Menu

Use of the SWAMECO Questionnaire Basel

University Hospital Basel logo

University Hospital Basel

Status

Completed

Conditions

Swallowing Difficulties

Treatments

Other: Self-report questionnaire

Study type

Observational

Funder types

Other

Identifiers

NCT04238559
2018-02187

Details and patient eligibility

About

A patient self-report questionnaire was developed that assesses subjective swallowing difficulties with medication intake, the SWAMECO questionnaire. It was validated in a highly specific population and will now be tested in the general population.

Full description

Based on a systematic literature review, a novel self-report questionnaire was developed in 2016 to assess subjective swallowing difficulties with medication intake and their practical consequences in ambulatory patients, the SWAMECO questionnaire. It consists of 30 items divided into 5 sections Complaints, Intensity, Localization, Coping strategies, and Adherence to medication. It was validated in people suffering from systemic sclerosis (SSc), a rare multisystem autoimmune disease that often leads to swallowing problems with food and liquids with progression. The aim of this study is now to validate the questionnaire in the general population. Patients presenting in the community pharmacy with a prescription of at least 3 different medications for a minimum of 3 months will fill in the questionnaire on site.

Enrollment

115 patients

Sex

All

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • aged 18 years or more
  • is living in the community setting
  • is receiving three or more medications for a period not less than three months, independently of the frequency of the intake

Exclusion criteria

  • patients who are not able to provide written conformed consent will be excluded

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems